Prab: Created page with "{{Short description|Tirzepatide and sleep apnea, Zepbound for obstructive sleep apnea, home sleep studies, prior authorization, and W8MD weight loss and sleep medicine care}} {{DISPLAYTITLE:Tirzepatide and sleep apnea}} NOTOC {{Infobox medical condition | name = Tirzepatide and sleep apnea | image = 250px | caption = Tirzepatide may help selected adults with obesity and moderate-to-severe obstructive sleep apnea when used with diet, activity,..."

2026-07-12T13:18:34Z

Created page with "{{Short description|Tirzepatide and sleep apnea, Zepbound for obstructive sleep apnea, home sleep studies, prior authorization, and W8MD weight loss and sleep medicine care}} {{DISPLAYTITLE:Tirzepatide and sleep apnea}} __NOTOC__ {{Infobox medical condition | name = Tirzepatide and sleep apnea | image = 250px | caption = Tirzepatide may help selected adults with obesity and moderate-to-severe obstructive sleep apnea when used with diet, activity,..."

New page

{{Short description|Tirzepatide and sleep apnea, Zepbound for obstructive sleep apnea, home sleep studies, prior authorization, and W8MD weight loss and sleep medicine care}}
{{DISPLAYTITLE:Tirzepatide and sleep apnea}}
__NOTOC__

{{Infobox medical condition
| name = Tirzepatide and sleep apnea
| image = [[File:Sleep-150.png|250px]]
| caption = Tirzepatide may help selected adults with obesity and moderate-to-severe obstructive sleep apnea when used with diet, activity, and medical supervision.
| field = [[Sleep medicine]], [[obesity medicine]], [[medical weight loss]]
| symptoms = [[Snoring]], witnessed apneas, choking or gasping during sleep, daytime sleepiness, morning headaches, fatigue
| risk_factors = [[Obesity]], [[overweight]], large neck circumference, [[insulin resistance]], [[hypertension]], aging, airway anatomy
| diagnostic_method = [[Home sleep study]], [[polysomnography]], [[apnea-hypopnea index]]
| treatment = [[CPAP]], [[APAP]], [[BiPAP]], weight loss, oral appliance therapy, surgery in selected patients, [[Zepbound]] in selected adults with obesity and moderate-to-severe OSA
| medication = [[Tirzepatide]], [[Zepbound]]
| related = [[Sleep apnea]], [[Obstructive sleep apnea]], [[Zepbound for sleep apnea]], [[Tirzepatide weight loss]], [[GLP-1 weight loss injections]]
}}

<div style="max-width:1120px; margin:0 auto; font-size:1.05em; line-height:1.65;">

<div style="background:linear-gradient(135deg,#f5f9ff,#eef7f0); border:1px solid #c9ddf2; border-radius:16px; padding:28px; margin:20px 0; box-shadow:0 3px 10px rgba(0,0,0,0.08);">

[[File:Sleep-150.png|right|170px|link=Sleep apnea|alt=W8MD sleep apnea and weight loss program]]

<h1 style="margin-top:0; color:#1f4e79;">Tirzepatide and Sleep Apnea</h1>

<p style="font-size:1.18em;">'''Tirzepatide and sleep apnea''' refers to the use of [[tirzepatide]], especially the brand-name medication '''[[Zepbound]]''', in selected adults with [[obesity]] and [[moderate-to-severe obstructive sleep apnea]]. Zepbound is the first medication approved by the U.S. Food and Drug Administration for treatment of moderate-to-severe obstructive sleep apnea in adults with obesity, when used with a [[reduced-calorie diet]] and increased [[physical activity]].<ref name="FDAZepboundOSA">{{cite web|url=https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea|title=FDA Approves First Medication for Obstructive Sleep Apnea|publisher=U.S. Food and Drug Administration|date=2024-12-20|accessdate=2026-07-12}}</ref></p>

<p>At '''[[W8MD Weight Loss, Sleep and MedSpa]]''', patients can receive integrated [[sleep medicine]] and [[medical weight loss]] care. W8MD can help diagnose [[obstructive sleep apnea]] with a convenient [[home sleep study]], treat sleep apnea with appropriate therapy, evaluate [[Zepbound for sleep apnea]], and help obtain insurance prior authorization for Zepbound when coverage is available and the patient qualifies.</p>

<div style="display:flex; flex-wrap:wrap; gap:14px; margin:22px 0;">

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">Home sleep study</div>
<div>Convenient testing for suspected [[obstructive sleep apnea]]</div>
</div>

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">Zepbound OSA</div>
<div>FDA-approved for selected adults with obesity and moderate-to-severe OSA</div>
</div>

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">Prior authorization</div>
<div>W8MD can help when insurance coverage is available and criteria are met</div>
</div>

<div style="flex:1; min-width:220px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:16px; text-align:center;">
<div style="font-size:1.8em; font-weight:bold; color:#0b5cad;">20+ years</div>
<div>Experienced weight loss doctors and sleep medicine care</div>
</div>

</div>

<div style="background:#fff8df; border:2px solid #f2c94c; border-radius:12px; padding:16px; margin:20px 0;">
'''W8MD program highlight:''' W8MD Weight Loss, Sleep and MedSpa Centers can diagnose and treat obstructive sleep apnea, provide convenient home sleep studies, coordinate CPAP/APAP/BiPAP care when appropriate, evaluate Zepbound for eligible adults with obesity and moderate-to-severe OSA, and help with insurance prior authorization when coverage is available.
</div>

<div style="text-align:center; margin:24px 0;">
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-45198 Book Brooklyn Appointment]</span>
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-48161 Book Philadelphia Appointment]</span>
</div>

</div>

[[File:W8MD-Team.jpg|thumb|right|350px|[[W8MD Weight Loss, Sleep and MedSpa]] provides physician-supervised weight loss, sleep apnea evaluation, home sleep studies, and GLP-1/GIP medication care.]]

==Overview==

'''Obstructive sleep apnea''' or '''OSA''' is a common sleep disorder in which breathing repeatedly stops or becomes shallow during sleep because the upper airway collapses or becomes blocked. OSA can lead to oxygen drops, fragmented sleep, daytime sleepiness, morning headaches, high blood pressure, heart strain, insulin resistance, and difficulty losing weight.

'''Tirzepatide''' is a once-weekly [[dual GIP and GLP-1 receptor agonist]]. It is the active ingredient in:

* '''[[Zepbound]]''' - used for [[chronic weight management]] and approved for [[moderate-to-severe obstructive sleep apnea]] in selected adults with obesity
* '''[[Mounjaro]]''' - used for [[type 2 diabetes]]

The FDA approved Zepbound for moderate-to-severe OSA in adults with obesity based on two randomized, double-blind, placebo-controlled studies in adults with obesity and moderate-to-severe OSA.<ref name="FDAZepboundOSA" />

==Why sleep apnea and obesity are connected==

Excess body weight can worsen sleep apnea through several mechanisms:

{{div col|colwidth=20em}}
* Increased fat around the neck and upper airway
* Narrower airway space during sleep
* Increased airway collapsibility
* Reduced lung volume when lying down
* Increased abdominal pressure
* Higher risk of [[insulin resistance]]
* Higher risk of [[hypertension]]
* More fatigue, cravings, and reduced activity
{{div col end}}

Not all sleep apnea is caused only by weight. Jaw structure, airway anatomy, age, sex, medications, alcohol use, nasal obstruction, and neuromuscular factors may also contribute. That is why W8MD emphasizes both diagnosis and individualized treatment rather than assuming weight loss alone is enough.

==How tirzepatide may help sleep apnea==

Tirzepatide may help selected adults with obesity-related obstructive sleep apnea mainly through weight reduction and metabolic improvement. By reducing body weight and improving cardiometabolic markers, tirzepatide may reduce upper-airway obstruction and improve sleep-disordered breathing in some patients.

Potential benefits may include:

{{div col|colwidth=20em}}
* Reduction in [[body weight]]
* Reduction in [[visceral fat]]
* Improved [[apnea-hypopnea index]]
* Reduced oxygen desaturation burden
* Improved sleep-related patient-reported outcomes
* Improved [[blood pressure]]
* Improved [[insulin resistance]]
* Reduced inflammation markers in some patients
* Better daytime energy for selected patients
{{div col end}}

In the SURMOUNT-OSA trials, tirzepatide reduced apnea-hypopnea index, body weight, hypoxic burden, high-sensitivity C-reactive protein, and systolic blood pressure, and improved sleep-related patient-reported outcomes.<ref name="NEJMSurmountOSA">{{cite journal|last1=Malhotra|first1=A.|title=Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity|journal=New England Journal of Medicine|year=2024|volume=391|pages=1193-1205|doi=10.1056/NEJMoa2404881|pmid=38912654}}</ref>

==What is Zepbound for sleep apnea?==

'''[[Zepbound for sleep apnea]]''' refers to the FDA-approved use of [[Zepbound]], the tirzepatide brand, for moderate-to-severe obstructive sleep apnea in adults with obesity. It should be used with a reduced-calorie diet and increased physical activity.<ref name="FDAZepboundOSA" />

Zepbound is not a replacement for proper sleep apnea diagnosis. Patients should know their sleep apnea severity, oxygen levels, symptoms, and treatment needs. Some patients may still need:

{{div col|colwidth=18em}}
* [[CPAP]]
* [[APAP]]
* [[BiPAP]]
* Oral appliance therapy
* Positional therapy
* Weight loss therapy
* ENT evaluation
* Repeat sleep testing
* Ongoing sleep medicine follow-up
{{div col end}}

==How W8MD can diagnose sleep apnea==

<div style="background:#f8fbff; border:1px solid #d6e6f5; border-radius:14px; padding:22px; margin:22px 0;">

<h2 style="margin-top:0; color:#1f4e79;">Convenient home sleep study through W8MD</h2>
[[File:Woman-losing-weight.jpeg|thumb|right|350px|Weight loss can improve obesity-related sleep apnea in selected patients, but sleep apnea still requires diagnosis, monitoring, and appropriate treatment.]]
[[File:Body mass index chart.svg|thumb|right|300px|[[Body mass index]] is one tool used to evaluate obesity-related risk and medication eligibility.]]
[[File:Obesity-waist circumference.svg|thumb|right|300px|[[Waist circumference]], [[central obesity]], and [[visceral fat]] are linked to metabolic risk and may worsen sleep apnea.]]
[[File:Obstructive sleep apnea.svg|thumb|right|300px|[[Obstructive sleep apnea]] occurs when the upper airway repeatedly collapses or narrows during sleep.]]

<p>W8MD can evaluate patients for suspected obstructive sleep apnea and arrange a convenient [[home sleep study]] when appropriate. Home sleep apnea testing can be useful in selected adults with signs and symptoms suggesting moderate-to-severe OSA. The American Academy of Sleep Medicine guideline recommends that if a single home sleep apnea test is negative, inconclusive, or technically inadequate, polysomnography should be performed for diagnosis.<ref name="AASMTesting">{{cite journal|last1=Kapur|first1=V. K.|title=Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea|journal=Journal of Clinical Sleep Medicine|year=2017|volume=13|issue=3|pages=479-504|doi=10.5664/jcsm.6506|pmid=28162150|pmc=5337595}}</ref></p>

<div style="display:flex; flex-wrap:wrap; gap:14px; margin:16px 0;">

<div style="flex:1; min-width:230px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Step 1: Sleep symptoms'''<br />
Review snoring, daytime fatigue, witnessed apneas, choking, gasping, morning headaches, and blood pressure.
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Step 2: Home testing'''<br />
A convenient home sleep study can measure breathing, oxygen changes, and sleep apnea risk.
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Step 3: Diagnosis'''<br />
W8MD reviews severity using results such as [[apnea-hypopnea index]], oxygen drops, and symptoms.
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-left:5px solid #0b5cad; border-radius:10px; padding:16px;">
'''Step 4: Treatment plan'''<br />
Options may include CPAP/APAP/BiPAP, weight loss, Zepbound evaluation, and follow-up.
</div>

</div>

</div>

==Symptoms that should prompt evaluation==

Patients should consider sleep apnea evaluation if they have:

{{div col|colwidth=18em}}
* Loud [[snoring]]
* Witnessed pauses in breathing
* Waking up choking or gasping
* Morning headaches
* Dry mouth on waking
* Daytime sleepiness
* Fatigue despite sleep
* Brain fog
* Irritability
* Resistant [[high blood pressure]]
* Nighttime urination
* Weight gain or difficulty losing weight
* Large neck circumference
{{div col end}}

==Health risks of untreated sleep apnea==

Untreated OSA can contribute to:

{{div col|colwidth=18em}}
* [[Hypertension]]
* [[Heart disease]]
* [[Atrial fibrillation]]
* [[Stroke]]
* [[Insulin resistance]]
* [[Type 2 diabetes]]
* Fatigue and accidents
* Poor concentration
* Morning headaches
* Mood changes
* Weight gain and cravings
* Reduced quality of life
{{div col end}}

==W8MD treatment approach==

W8MD’s strength is the combination of '''sleep medicine''' and '''obesity medicine'''. Many patients with obesity and sleep apnea need both airway treatment and weight-loss treatment.

W8MD can help with:

{{div col|colwidth=20em}}
* [[Home sleep study]]
* Sleep apnea diagnosis
* [[CPAP]] care coordination
* [[APAP]] or [[BiPAP]] support when appropriate
* Evaluation for [[Zepbound for sleep apnea]]
* Insurance prior authorization for Zepbound when coverage is available
* [[Tirzepatide weight loss]]
* [[GLP-1 weight loss injections]]
* Nutrition and protein planning
* [[Meal replacements]]
* [[Low-carbohydrate diet]] counseling
* [[Exercise counseling]]
* [[Resistance training]]
* Side-effect management
* Long-term [[weight maintenance]]
{{div col end}}

==Zepbound prior authorization for sleep apnea==

Insurance coverage for Zepbound for sleep apnea varies by plan. When coverage is available and the patient qualifies, W8MD physicians can help submit prior authorization documentation.

Prior authorization may require:

{{div col|colwidth=20em}}
* Diagnosis of moderate-to-severe [[obstructive sleep apnea]]
* Sleep study results, including [[apnea-hypopnea index]]
* Current [[BMI]]
* Diagnosis of [[obesity]]
* Weight history
* Prior treatment history
* CPAP/APAP/BiPAP history when applicable
* Medical visit notes
* Medication list
* Weight-related comorbidities
* Insurance-specific forms
{{div col end}}

Approval is not guaranteed. Insurance decisions depend on plan rules, pharmacy benefit coverage, diagnosis, documentation, prior treatment requirements, exclusions, and payer policies.

==Why W8MD is different==

<div style="background:#eef7f0; border:1px solid #b8dfc1; border-radius:14px; padding:22px; margin:22px 0;">

<h2 style="margin-top:0; color:#1f4e79;">W8MD Sleep + Weight Loss Advantage</h2>

<div style="display:flex; flex-wrap:wrap; gap:14px;">

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:1.7em; font-weight:bold; color:#237a3b;">20+ years</div>
<div>Experienced weight loss doctors with over 20 years of clinical experience.</div>
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:1.7em; font-weight:bold; color:#237a3b;">Sleep testing</div>
<div>Convenient [[home sleep study]] testing for suspected obstructive sleep apnea.</div>
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:1.7em; font-weight:bold; color:#237a3b;">Zepbound PA</div>
<div>Prior authorization help for eligible patients when insurance coverage is available.</div>
</div>

<div style="flex:1; min-width:230px; background:#ffffff; border-radius:10px; padding:16px; text-align:center;">
<div style="font-size:1.7em; font-weight:bold; color:#237a3b;">Success focus</div>
<div>Medication, nutrition, sleep treatment, and maintenance support in one program.</div>
</div>

</div>

</div>

==Weight loss success story themes==

W8MD has helped thousands of patients work toward healthier weight, improved sleep, and better metabolic health. Individual results vary, but patients in medically supervised GLP-1/GIP and sleep medicine programs often report:

{{div col|colwidth=20em}}
* Less hunger
* Reduced [[food noise]]
* Smaller portions
* Improved [[satiety]]
* Better ability to follow a nutrition plan
* Better daytime energy when sleep apnea is treated
* Improved blood pressure in some patients
* Improved blood sugar markers in some patients
* Better confidence and mobility
* Improved long-term weight maintenance skills
{{div col end}}

These are general success themes and are not a guarantee of individual results. Outcomes depend on medical history, medication response, dose, adherence, sleep apnea severity, CPAP/APAP/BiPAP use when needed, nutrition, activity, side effects, medication access, and follow-up.

==Tirzepatide dosing for sleep apnea and weight loss==

Zepbound is given as a once-weekly [[subcutaneous injection]]. Dosing starts low and increases gradually to improve tolerability. Patients should follow the prescribing clinician’s instructions and the official medication guide.

{| class="wikitable" style="width:100%;"
! Dose
! Typical role
! Patient education point
|-
| 2.5 mg once weekly
| Starting dose
| Helps the body adjust; not typically a maintenance dose
|-
| 5 mg once weekly
| Escalation or maintenance for weight management
| May be used depending on response and tolerability
|-
| 7.5 mg once weekly
| Escalation step
| Used before higher doses when appropriate
|-
| 10 mg once weekly
| Maintenance option
| Recommended maintenance option for OSA indication in appropriate patients
|-
| 12.5 mg once weekly
| Escalation step
| Used before 15 mg when appropriate
|-
| 15 mg once weekly
| Maximum dose
| Recommended maintenance option for OSA indication in appropriate patients
|}

The Zepbound prescribing information lists recommended maintenance dosages for moderate-to-severe OSA as 10 mg or 15 mg once weekly.<ref name="ZepboundLabel">{{cite web|url=https://pi.lilly.com/us/zepbound-uspi.pdf|title=Zepbound prescribing information|publisher=Eli Lilly and Company|accessdate=2026-07-12}}</ref>

==Tirzepatide is not a substitute for emergency care or airway treatment==

Patients should not stop CPAP, APAP, BiPAP, oxygen, oral appliance therapy, or other prescribed sleep apnea treatment without discussing it with a clinician. Tirzepatide-related weight loss takes time, while airway treatment may be needed immediately to prevent oxygen drops and sleep fragmentation.

Patients should seek urgent medical care for:

{{div col|colwidth=20em}}
* Chest pain
* Severe shortness of breath
* Fainting
* Severe allergic reaction
* Severe abdominal pain
* Confusion
* Severe oxygen-related symptoms
* New neurological symptoms
{{div col end}}

==Common side effects of tirzepatide==

Common [[tirzepatide side effects]] may include:

{{div col|colwidth=18em}}
* [[Nausea]]
* [[Diarrhea]]
* [[Vomiting]]
* [[Constipation]]
* Abdominal discomfort
* [[Gastroesophageal reflux disease]]
* Burping
* Bloating
* Injection-site reactions
* [[Fatigue]]
* Reduced appetite
{{div col end}}

Side effects often occur during [[tirzepatide dose escalation]] and may improve with smaller meals, slower eating, hydration, lower-fat food choices, and medical dose adjustment.

==Important safety information==

Tirzepatide products are not appropriate for everyone. Patients should discuss risks and benefits with a healthcare provider, especially if they have:

{{div col|colwidth=20em}}
* Personal or family history of [[medullary thyroid carcinoma]]
* [[Multiple Endocrine Neoplasia syndrome type 2]]
* History of [[pancreatitis]]
* [[Gallbladder disease]]
* Severe gastrointestinal disease
* [[Kidney disease]]
* [[Type 1 diabetes]]
* Use of [[insulin]] or [[sulfonylurea]]
* [[Pregnancy]] or plans for pregnancy
* Breastfeeding
* Eating disorder history
* Severe dehydration risk
* Prior serious allergic reaction to tirzepatide
{{div col end}}

The prescribing information for Zepbound includes a boxed warning related to thyroid C-cell tumors observed in animal studies and contraindications for patients with personal or family history of medullary thyroid carcinoma or MEN2.<ref name="ZepboundLabel" />

==Nutrition and lifestyle while using tirzepatide for OSA==

For patients with obesity and sleep apnea, medication works best with lifestyle support.

W8MD may advise patients to focus on:

{{div col|colwidth=18em}}
* Protein-first meals
* Smaller portions
* Hydration
* Non-starchy vegetables
* Lower-glycemic carbohydrates
* Avoiding large greasy meals
* Avoiding late-night heavy meals
* Limiting alcohol near bedtime
* [[Resistance training]]
* Walking
* Sleep schedule consistency
* CPAP/APAP/BiPAP adherence when prescribed
{{div col end}}

==Tirzepatide and sleep apnea in New York, New Jersey, Connecticut, Pennsylvania, and Delaware==

Patients searching for '''tirzepatide sleep apnea near me''', '''Zepbound for sleep apnea NYC''', '''home sleep study Brooklyn''', '''sleep apnea weight loss New Jersey''', '''Zepbound prior authorization Philadelphia''', or '''sleep apnea doctor Pennsylvania''' often want a practice that can address both sleep apnea and obesity.

W8MD serves patients in and around:

{{div col|colwidth=18em}}
* [[Brooklyn]]
* [[New York City]]
* [[Manhattan]]
* [[Queens]]
* [[Staten Island]]
* [[Long Island]]
* [[New Jersey]]
* [[Connecticut]]
* [[Philadelphia]]
* [[Pennsylvania]]
* [[Delaware]]
* [[Greater Philadelphia]]
{{div col end}}

Services and medication options may vary by location, state rules, insurance plan, pharmacy availability, and clinical evaluation.

==Frequently asked questions==

===Can tirzepatide help sleep apnea?===

Yes, in selected adults with obesity and moderate-to-severe obstructive sleep apnea. Zepbound, which contains tirzepatide, is FDA-approved for this use when combined with reduced-calorie diet and increased physical activity.<ref name="FDAZepboundOSA" />

===Is Zepbound approved for sleep apnea?===

Yes. The FDA approved Zepbound for treatment of moderate-to-severe obstructive sleep apnea in adults with obesity.<ref name="FDAZepboundOSA" />

===Can W8MD diagnose sleep apnea?===

Yes. W8MD can evaluate symptoms and arrange a convenient [[home sleep study]] when appropriate. If results are negative, inconclusive, or technically inadequate despite strong clinical suspicion, in-lab polysomnography may be needed.

===Can W8MD treat sleep apnea?===

Yes. W8MD can help manage sleep apnea care, including home sleep testing, CPAP/APAP/BiPAP coordination when appropriate, weight-loss treatment, and follow-up.

===Can W8MD help with Zepbound prior authorization for sleep apnea?===

Yes. When insurance coverage is available and the patient qualifies, W8MD physicians can help submit prior authorization documentation for Zepbound for sleep apnea. Approval depends on the patient’s insurance plan.

===Do I still need CPAP if I use Zepbound?===

Some patients may still need CPAP, APAP, BiPAP, or another airway treatment. Patients should not stop prescribed sleep apnea therapy without clinician guidance.

===How do I know if my sleep apnea is moderate or severe?===

Severity is usually based on the [[apnea-hypopnea index]] from a sleep study, oxygen findings, symptoms, and clinical judgment. AHI of 15 to 29 events per hour is commonly considered moderate, and 30 or more events per hour is commonly considered severe.

===Can weight loss cure sleep apnea?===

Weight loss can improve sleep apnea in many patients, but it does not guarantee cure. Airway anatomy, age, jaw structure, nasal obstruction, alcohol use, and other factors may continue to contribute.

==Book a sleep apnea and tirzepatide appointment==

<div style="background:linear-gradient(135deg,#f5f9ff,#eef7f0); border:1px solid #c9ddf2; border-radius:16px; padding:24px; margin:28px 0; box-shadow:0 3px 10px rgba(0,0,0,0.08);">

[[File:W8MD-Team.jpg|right|220px|link=W8MD Weight Loss, Sleep and MedSpa|alt=W8MD Weight Loss Sleep and MedSpa team]]

<h2 style="margin-top:0; color:#1f4e79;">Request an appointment with W8MD</h2>

<p>W8MD offers physician-supervised [[medical weight loss]], [[sleep apnea]] evaluation, convenient [[home sleep study]] testing, [[Zepbound for sleep apnea]] evaluation, [[tirzepatide weight loss]], [[GLP-1 weight loss injections]], insurance prior authorization support when coverage is available, and long-term maintenance care in Brooklyn, NY and Philadelphia, PA.</p>

<div style="display:flex; flex-wrap:wrap; gap:16px; margin:20px 0;">

<div style="flex:1; min-width:280px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:20px;">
<h3 style="margin-top:0; color:#1f4e79;">Brooklyn, NY Office</h3>
<p><strong>Phone:</strong> <span style="font-size:1.25em; color:#0b5cad; font-weight:bold;">718-946-5500</span></p>
<p>For patients searching for [[Zepbound for sleep apnea NYC]], [[home sleep study Brooklyn]], [[sleep apnea doctor NYC]], [[tirzepatide New Jersey]], or [[sleep apnea weight loss Connecticut]].</p>
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-45198 Book Brooklyn Appointment]</span>
</div>

<div style="flex:1; min-width:280px; background:#ffffff; border:1px solid #b8d7f0; border-radius:12px; padding:20px;">
<h3 style="margin-top:0; color:#1f4e79;">Philadelphia, PA Office</h3>
<p><strong>Phone:</strong> <span style="font-size:1.25em; color:#0b5cad; font-weight:bold;">215-676-2334</span></p>
<p>For patients searching for [[Zepbound for sleep apnea Philadelphia]], [[home sleep study Philadelphia]], [[sleep apnea doctor Pennsylvania]], [[tirzepatide Pennsylvania]], or [[sleep apnea weight loss Delaware]].</p>
<span class="mw-ui-button mw-ui-progressive mw-ui-big">[https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-48161 Book Philadelphia Appointment]</span>
</div>

</div>

<div style="background:#fff3cd; border:1px solid #ffe08a; border-radius:10px; padding:14px; margin:18px 0;">
'''Important:''' Please do not submit sensitive medical information, Social Security numbers, insurance ID numbers, or urgent medical concerns through online appointment request forms. If this is a medical emergency, call '''911'''.
</div>

</div>

==Related W8MD and GLP-1 pages==

{{div col|colwidth=18em}}
* [[Zepbound for sleep apnea]]
* [[Tirzepatide and sleep apnea]]
* [[Sleep apnea screening]]
* [[Home sleep study]]
* [[Obstructive sleep apnea]]
* [[CPAP]]
* [[APAP]]
* [[BiPAP]]
* [[Zepbound for weight loss]]
* [[Tirzepatide weight loss]]
* [[Tirzepatide injection]]
* [[Tirzepatide side effects]]
* [[Tirzepatide dose escalation]]
* [[Mounjaro for weight loss]]
* [[GLP-1 weight loss injections]]
* [[Semaglutide weight loss]]
* [[Wegovy for weight loss]]
* [[Ozempic for weight loss]]
* [[Food noise]]
* [[Satiety]]
* [[Appetite regulation]]
* [[Chronic weight management]]
* [[Medical weight loss]]
* [[Obesity medicine]]
{{div col end}}

==Relevant WikiMD links==

* [https://wikimd.org/wiki/Tirzepatide Tirzepatide on WikiMD]
* [https://wikimd.org/wiki/Zepbound Zepbound on WikiMD]
* [https://wikimd.org/wiki/Obstructive_sleep_apnea Obstructive sleep apnea on WikiMD]
* [https://wikimd.org/wiki/Sleep_apnea Sleep apnea on WikiMD]
* [https://wikimd.org/wiki/CPAP CPAP on WikiMD]
* [https://wikimd.org/wiki/Obesity Obesity on WikiMD]
* [https://wikimd.org/wiki/Weight_loss Weight loss on WikiMD]

==External links==

* [https://www.fda.gov/news-events/press-announcements/fda-approves-first-medication-obstructive-sleep-apnea FDA - Zepbound approval for obstructive sleep apnea]
* [https://pi.lilly.com/us/zepbound-uspi.pdf Zepbound prescribing information]
* [https://zepbound.lilly.com/sleep-apnea Official Zepbound sleep apnea information]
* [https://www.nejm.org/doi/abs/10.1056/NEJMoa2404881 Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity - NEJM]
* [https://pubmed.ncbi.nlm.nih.gov/38912654/ Tirzepatide for obstructive sleep apnea and obesity - PubMed]
* [https://pmc.ncbi.nlm.nih.gov/articles/PMC5337595/ AASM guideline for diagnostic testing for adult obstructive sleep apnea]
* [https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-45198 W8MD Brooklyn appointment request]
* [https://www.patientfusion.com/doctor/prab-tumpati-md-sleep-obesity-48161 W8MD Philadelphia appointment request]
{{GLP-1}}
{{Obesity medicine}}
{{Sleep medicine}}
{{Weight loss}}

</div>

[[Category:W8MD]]
[[Category:Sleep apnea]]
[[Category:Obstructive sleep apnea]]
[[Category:Home sleep study]]
[[Category:CPAP]]
[[Category:GLP-1]]
[[Category:GLP-1 weight loss]]
[[Category:Tirzepatide]]
[[Category:Zepbound]]
[[Category:Medical weight loss]]
[[Category:Anti-obesity medications]]
[[Category:Obesity medicine]]
[[Category:Sleep medicine]]
[[Category:Chronic weight management]]
[[Category:Prescription weight loss medications]]
[[Category:Weight loss injections]]
[[Category:Brooklyn sleep apnea]]
[[Category:New York City sleep apnea]]
[[Category:New Jersey sleep apnea]]
[[Category:Connecticut sleep apnea]]
[[Category:Philadelphia sleep apnea]]
[[Category:Pennsylvania sleep apnea]]
[[Category:Delaware sleep apnea]]

Tirzepatide and sleep apnea - Revision history